We are live on ! Find out more
HA

HC Advisors Portfolio holdings

AUM $165M
1-Year Est. Return 20.85%
This Fund
S&P 500
This Quarter Est. Return
+4.58%
1 Year Est. Return
+20.85%
3 Year Est. Return
+63.52%
5 Year Est. Return
+65.27%
10 Year Est. Return
AUM
$155M
AUM Growth
+$8.44M
Cap. Flow
+$3.22M
Cap. Flow %
2.08%
Top 10 Hldgs %
63.18%
Holding
102
New
15
Increased
35
Reduced
19
Closed
13

Sector Composition

Rank Sector Weight
1 Miscellaneous 86.97%
2 Financials 2.81%
3 Technology 2.61%
4 Healthcare 2.33%
5 Consumer Discretionary 1.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IWV icon
26
iShares Russell 3000 ETF
IWV
$20.1B
$1.01M 0.65%
4,270
VBR icon
27
Vanguard Morningstar Small-Cap Value ETF
VBR
$36.6B
$996K 0.64%
6,012
AMZN icon
28
Amazon
AMZN
$2.68T
$950K 0.61%
6,140
+620
+11% +$98.3K
VOO icon
29
Vanguard S&P 500 ETF
VOO
$1.04T
$928K 0.6%
2,548
PHYS icon
30
Sprott Physical Gold
PHYS
$15.4B
$899K 0.58%
67,036
+1,210
+2% +$17.2K
HD icon
31
Home Depot
HD
$305B
$888K 0.57%
2,908
+93
+3% +$25.6K
PDX
32
PIMCO Dynamic Income Strategy Fund
PDX
$935M
$781K 0.5%
75,413
-8,505
-10% -$82.1K
PSLV icon
33
Sprott Physical Silver Trust
PSLV
$13.1B
$780K 0.5%
88,891
+185
+0.2% +$1.74K
MO icon
34
Altria Group
MO
$117B
$726K 0.47%
+14,182
New +$635K
VEA icon
35
Vanguard FTSE Developed Markets ETF
VEA
$234B
$684K 0.44%
13,924
VZ icon
36
Verizon
VZ
$214B
$681K 0.44%
+11,714
New +$661K
ALXO icon
37
ALX Oncology
ALXO
$261M
$660K 0.43%
8,945
-858
-9% -$67.5K
PAAS icon
38
Pan American Silver
PAAS
$20.1B
$602K 0.39%
20,041
+299
+2% +$9.71K
CRSP icon
39
CRISPR Therapeutics
CRSP
$5.01B
$564K 0.36%
4,630
+412
+10% +$62.2K
IWF icon
40
iShares Russell 1000 Growth ETF
IWF
$123B
$537K 0.35%
8,840
VTWG icon
41
Vanguard Russell 2000 Growth ETF
VTWG
$1.44B
$525K 0.34%
2,398
MSFT icon
42
Microsoft
MSFT
$3.69T
$514K 0.33%
2,181
+173
+9% +$40.1K
VTHR icon
43
Vanguard Russell 3000 ETF
VTHR
$4.77B
$471K 0.3%
2,550
VBK icon
44
Vanguard Morningstar Small-Cap Growth ETF
VBK
$22.8B
$467K 0.3%
1,699
VCIT icon
45
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$68.7B
$460K 0.3%
4,949
KO icon
46
Coca-Cola
KO
$382B
$451K 0.29%
8,559
+65
+0.8% +$3.27K
DAL icon
47
Delta Air Lines
DAL
$51.9B
$429K 0.28%
8,879
+500
+6% +$22.1K
RSP icon
48
Invesco S&P 500 Equal Weight ETF
RSP
$98.3B
$397K 0.26%
2,800
PFE icon
49
Pfizer
PFE
$157B
$395K 0.26%
10,911
+227
+2% +$8.06K
INTC icon
50
Intel
INTC
$513B
$380K 0.25%
5,940
-166
-3% -$9.89K

Similar funds

HC Advisors's Q1 2021 Portfolio in Review

As of Q1 2021, HC Advisors held 102 positions worth $155M, up 5.8% from $146M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

HC Advisors's Q1 2021 filing shows 15 new, 35 increased, 19 reduced and 13 closed positions. Its largest new stake was Verizon: 11,714 shares worth $681K. The largest sale was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $921K.

By sector, the portfolio is most concentrated in Miscellaneous at 87% of assets, up from 87% a quarter earlier, followed by Financials and Technology.

  • HC Advisors's largest Q1 2021 buy was Verizon: 11,714 shares worth $681K.
  • HC Advisors added most to Bank of America in Q1 2021, an estimated $1.22M increase.
  • HC Advisors's biggest Q1 2021 reduction was Cytokinetics, cutting an estimated $442K.
  • HC Advisors fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q1 2021, selling an estimated $921K.
  • HC Advisors's ten largest holdings make up 63% of its $155M portfolio in Q1 2021.
  • HC Advisors opened 15 new positions and closed 13 in Q1 2021.
  • HC Advisors's portfolio value rose 5.8% quarter-over-quarter to $155M.

Based on HC Advisors's 13F filing for Q1 2021, filed 7 May 2021.